(MENAFN- Ameliorate Digital Consultancy)
The global PCR and real-time PCR molecular diagnostics market is predicted to progress at a CAGR of 4.1% from 2023 to 2033. The market is valued at US$ 5 billion in 2023 and is thereby expected to reach US$ 7.5 billion by 2033-end.
Testing for infectious diseases is likely to increase as the years go by, attributed to the high prevalence of sexually-transmitted infections, respiratory infections, and hepatitis C and B. The use of polymerase chain reaction (PCR) molecular diagnostics has significantly increased in recent years. When it comes to identifying pathogenic DNA for many communicable diseases, PCR testing is immensely effective. The reach of PCR and RT-PCR tests is being expanded to find cures for serious illnesses.
Download Free Sample Copy of This Report:
Competitive Landscape
Leading companies in the global PCR and real-time PCR molecular diagnostics market are focusing on the local supply of diagnostic tools, safety regulations, and product standards to remain afloat. They are also making collaborations with other players, government agencies, and research institutes to deepen their geographical presence.
Top market players are concentrating on quality control by introducing advanced testing kits to lower the environmental impact. Key PCR and real-time PCR molecular diagnostic device providers should focus on supply chain management to gain a competitive edge in the market.
For instance :
Abbott Laboratories received an emergency use authorization (EUA) from the U.S. FDA to introduce its RealTime SARS-CoV-2 assay based on PCR for qualitative nucleic acid detection. In March 2020, Bio-Rad Laboratories partnered with testing labs worldwide to develop and implement RT-PCR products for the detection of novel coronavirus. The extensive use of these products is the Assurance Scientific Laboratories in Birmingham, Alabama. It uses Bio-Rad's CFX384 Touch Real-Time PCR Detection Systems.
Share Your Requirements & Get Customized Reports:
Key Companies Profiled:
Abbott Laboratories Bio-Rad Laboratories Danaher Corporation Hologic, Inc. Genomic Health Seegene, Inc. QIAGEN N.V. GRIFOLS
Full Access to this Report Is Available:
Key Segmentation :
By Technology : Traditional PCR Real-time PCR Digital PCR
By Product : Instruments Reagents Consumables
By Application : Infectious Disease Testing Oncology Testing Genetic Testing Others
By End User : Hospitals Diagnostic Laboratories Academic & Research Centers Others
By Region : North America Europe Asia Pacific Latin America Middle East & Africa
Questionnaire answered in the report include:
How the industry has grown? What is the present and future outlook on the basis of region? What are the challenges and opportunities? Why the consumption in region? In which year segment is expected to overtake segment?
For More Insights of Fact.MR Trending Report:-
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email:
MENAFN23012023004660010643ID1105469267
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.